2024 World Molecular Diagnostics Market in 92 Countries: 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USAThe companies profiled in the report include:Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Cepheid/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USAThe companies profiled in the report include:Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Cepheid/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
More Publications
2024 Costa Rica Molecular Diagnostics Market Shares--Competitive Analysis of Leading and Emerging Market Players
US$ 950.00
June 2024
-
2024 Synthes First Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Orthopedics Industry
US$ 750.00
April 2024
-
2017 Global MRI Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers
US$ 6,660.00
March 2017
548 pages
Global Transfusion Medicine Market, 2019-2023: Immunohematology and NAT Analyzers and Reagents-Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities
US$ 27,500.00
November 2019
775 pages
2017-2021 World Mycoplasma Diagnostics Market: Emerging Opportunities and Growth Strategies
US$ 3,915.00
February 2017
202 pages